Add to ORKGThe effects of clinical-trial funding on the interpretation of trial results are poorly understood. We examined how such support affects physicians’ reactions to trials with a high, medium, or low level of methodologic rigor
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Purpose: Because financial conflicts of interest (FCOIs) may potentially influence patient care, hos...
Clinical research should conform to high standards of ethical and scientific integrity, given that h...
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abst...
BACKGROUND: Most studies are inclined to report positive rather than negative or inconclusive result...
This paper contributes to the ongoing debate on the reliability of published research. In particular...
Background: Clinical trial registries are in widespread use to promote transparency around trials an...
ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of ...
The partnership between medical academia and the pharmaceutical industry has been scrutinized for is...
Aims: In 2017 alone, $12.7 billion was spent on clinical trial research, though basis for conducting...
Academics are debating whether industry funding influ-ences research findings and conclusions.1–7 Th...
Background—Prior work indicates that therapeutic trials funded by for-profit organizations are more ...
Background: Healthcare decisions are ideally based on clinical trial results, published in study reg...
Sir Benjamin Djulbegovic and colleagues1 suggest that government or non-profit-organisation-funded t...
OBJECTIVE: To investigate the distribution, design characteristics, and dissemination of clinical tr...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Purpose: Because financial conflicts of interest (FCOIs) may potentially influence patient care, hos...
Clinical research should conform to high standards of ethical and scientific integrity, given that h...
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abst...
BACKGROUND: Most studies are inclined to report positive rather than negative or inconclusive result...
This paper contributes to the ongoing debate on the reliability of published research. In particular...
Background: Clinical trial registries are in widespread use to promote transparency around trials an...
ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of ...
The partnership between medical academia and the pharmaceutical industry has been scrutinized for is...
Aims: In 2017 alone, $12.7 billion was spent on clinical trial research, though basis for conducting...
Academics are debating whether industry funding influ-ences research findings and conclusions.1–7 Th...
Background—Prior work indicates that therapeutic trials funded by for-profit organizations are more ...
Background: Healthcare decisions are ideally based on clinical trial results, published in study reg...
Sir Benjamin Djulbegovic and colleagues1 suggest that government or non-profit-organisation-funded t...
OBJECTIVE: To investigate the distribution, design characteristics, and dissemination of clinical tr...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Purpose: Because financial conflicts of interest (FCOIs) may potentially influence patient care, hos...
Clinical research should conform to high standards of ethical and scientific integrity, given that h...